Matches in Nanopublications for { ?s ?p "[Nine percent of patients with wild-type KRAS in primary tumors who received anti-EGFR treatment had mutant KRAS in metastases, while 11.3% patients with mutant KRAS primary tumors had wild-type KRAS in the metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Nine percent of patients with wild-type KRAS in primary tumors who received anti-EGFR treatment had mutant KRAS in metastases, while 11.3% patients with mutant KRAS primary tumors had wild-type KRAS in the metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1259954.RAskx6Xmm6SdFvGUp1tpVbWKySxS9sVH6TpFYL60TCMjM130_assertion description "[Nine percent of patients with wild-type KRAS in primary tumors who received anti-EGFR treatment had mutant KRAS in metastases, while 11.3% patients with mutant KRAS primary tumors had wild-type KRAS in the metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259954.RAskx6Xmm6SdFvGUp1tpVbWKySxS9sVH6TpFYL60TCMjM130_provenance.